ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Gentex Announces Acquisition of BioConnect

ZEELAND, Mich., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX) announced today that it has acquired Toronto-based BioConnect, a leader in biometric authentication solutions. The company provides a market-leading, multi-modal authentication software platform for the security and access control industry.

Gentex is a technology company and long-time supplier of electro-optical products for the global automotive, aerospace, fire protection, and medical industries. The company is best known for automotive electronics, but continues to grow its capabilities in vision systems, sensing, AI development, biometrics, home automation, and other smart technologies.

BioConnect provides an enterprise biometric authentication & security platform that verifies a person’s identity across physical, IoT and digital applications. The result is exact identity assurance, advanced cybersecurity, and the protection of company assets, people, data, and IP.

“Biometric technology is playing an increasingly important role in the industries in which we operate, including automotive, aerospace, medical, and smart home,” said Gentex Chief Operations Officer and Chief Technology Officer Neil Boehm. “This acquisition not only provides Gentex with a strong foothold in the security and access control industry, but also the expertise to continue developing advanced biometric solutions for the industries we currently serve.”

“We’re excited to combine our technologies and capabilities with those of Gentex,” said Rob Douglas, BioConnect Founder and CEO. “Gentex’s engineering capabilities, software expertise, and quality, high-volume electronics manufacturing will not only help us grow in the security and access control space but also expand into new platforms and industries.”

Gentex sees synergy between BioConnect and EyeLock, an iris biometric technology obtained by Gentex in the purchase of VOXX International earlier this year. Under the leadership of Douglas, BioConnect and EyeLock personnel will work together to form Gentex’s Security & Access Control team, which has already begun collaborating on ways to utilize EyeLock hardware in BioConnect platforms in unique ways.

BioConnect currently has over 1,500 customers across many regulated industries, including data storage, healthcare, financial services, education, and manufacturing. The company has carved a niche by providing holistic security systems for IT data centers, with eight of the top 10, US-headquartered data centers already utilizing BioConnect to protect physical access to their highly sensitive operations.

About BioConnect
Established in 2010 by IT professionals for IT professionals, BioConnect provides an enterprise biometric and multi-factor authentication & security platform to establish stronger identity trust for the protection of the most valuable enterprise assets -- people, data and IP.

About Gentex
Founded in 1974, Gentex Corporation (NASDAQ: GNTX) is a technology company that leverages its core competencies, strategic partnerships, acquisitions, and ongoing research to create market-leading positions in a variety of verticals. You can view some of the Company’s latest technology at www.gentex.com.

Gentex Media Contact
Craig Piersma
(616) 772-1590 x4316
craig.piersma@gentex.com
Gentex Investor Relations Contact
Josh O’Berski
(616) 772-1800 x5814
josh.oberski@gentex.com 
  



Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.62
-4.76 (-2.05%)
AAPL  280.23
-3.92 (-1.38%)
AMD  217.10
-0.50 (-0.23%)
BAC  54.58
+0.48 (0.90%)
GOOG  316.76
-3.86 (-1.20%)
META  666.15
+26.55 (4.15%)
MSFT  477.90
+0.17 (0.04%)
NVDA  182.02
+2.43 (1.35%)
ORCL  211.00
+3.27 (1.57%)
TSLA  448.17
+1.43 (0.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.